chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MYOCARDITIS; PERICARDITIS; This spontaneous report received from a parent via a company representative via social media concerned a 19 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin and batch number and expiry date were not reported) dose was not reported, 1 total (first dose), administered on an unspecified date for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number and expiry were not reported) dose, 1 total start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced myocarditis, and pericarditis (dose number in series 2) due to which patient was hospitalized for an unspecified number of days. Reporter stated that "My healthy 19-year-old son was just recently hospitalized because of your booster. Both myocarditis and pericarditis. Tell me again how safe this was? Is he going to have life-long issues now? Oh, and he only got the booster because his college held his education over his head unless he got the booster. And yes it was J and J not the others". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the myocarditis and pericarditis was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20220253441-COVID-19 VACCINE AD26.COV2.S-Myocarditis, Pericarditis. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
No adverse effects reported; The primary reporter states an expired dose of VAQTA was given on 9/9/2019; This spontaneous report was received from a registered nurse, concerning a patient of an unknown age and gender. The patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications were not reported.   On 09-SEP-2019, an expired dose of Hepatitis A Vaccine, inactivated (VAQTA) (expired product administered) lot number R027987, expiration date 09-AUG-2019, was administered per intramuscular route, to the patient (strength, dose and frequency were not reported) for prophylaxis. No adverse effects were reported. The outcome of the event was not reported.
Abdominal pain extreme bloating some upper abdominal pain off and on for six days. Went to dr recommended gasx pepto bismol loose stools six days
Went to chair- very warm, sweating, clammy. Heart racing. Spoke to nurse- they had no crash box on site. Nurse had to call 911 to get assistance for me. Nurse told me to take deep breaths, gave me apple juice. Paramedics and ambulance came. Said my heart rate was 120, blood pressure was 166.
Information from school nurse, swelling of deltoid area 4 inches reddened and firm. No c/o pain at site, no fever. 1/25/05 arm no longer sore or inflamed.
A little Sore Injection Site Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little Sore Injection Site Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (A little Sore Injection Site Pain). On 10-Mar-2021, VACCINATION SITE PAIN (A little Sore Injection Site Pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Rapid heartbeat with palpitations and chest discomfort. Received EKG, stress test and echocardiogram. Had to wear at home heart monitor. All tests were negative. Received no treatment. It went on for weeks. My other symptom was tinnitus. I had a swishing sound in my right away for a few days.
Information has been received from a consumer concerning her son, a 15 month old male patient who on 04-NOV-2005 was vaccinated with a 0.5ml dose of MMR II subcutaneously. There were no concomitant medications. Pertinent medical history and drug reactions/allergies were reported as none. On 07-NOV-2005, three days after getting vaccine, the patient developed Asperger syndrome. The patient had sought unspecified medical attention. Genetic test was performed, but the result was not reported. At the time of report, the patient was recovering. Upon internal review, Asperger syndrome was determined to be an other important medical event. Additional information has been requested.
nerve pain; like electrical shocks; redness at injection site, intensified and bigger; swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included EPINEPHRINE BITARTRATE (ASTHMAHALER) and GABAPENTIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Around the third or fourth day the redness at the injection site intensified. It started to go away on day 5 but it came back on 28-JAN-2021. It is much more red, swollen, and bigger this time. She was very concerned and wanted to know whether nerve pain was commonly reported and when she should expect the delayed reaction to get better. Treatment information included acetaminophen and ice pack.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021:
Problems with concentration, couldn't concentrate; Trouble finding her words, could't speak properly, experience kind of aphasia symptoms; Mind fogginess, brain fog; Hives; Difficulty remembering names; Difficult to do writing tasks; Heart race; nervousness of getting the vaccine; Swallen in the injection site; Redness in the injection site; A spontaneous report was received from a 70-year-old, female consumer who received Moderna's COVID-19 vaccine and developed problems with concentration, could not speak properly, trouble finding her words, brain fog/ mind fogginess, hives, redness and swelling at the injection site, difficult to do writing tasks, difficulty remembering things, increment in heartbeat, heart racing, nervousness of getting the vaccine.   The patient's past medical history, as provided by the reporter, included long lasting, bad side effects following the influenza vaccine. Concomitant medication reported included vitamins.  On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 28 Dec 2020, four hours after receiving the vaccine, the patient developed problems with concentration, trouble finding her words, mind fogginess, hives, redness and swelling at the injection site, difficult to do writing tasks, difficulty remembering things, increment heart beat.  Treatment for the event included tylenol and ibuprofen.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome for the events, developed problems with concentration, trouble finding her words, mind fogginess, hives, redness and swelling at the injection site, increment heartbeat were considered as recovered on 30 Dec 2020. At the time of report outcome of the events difficult to do writing tasks, difficulty remembering things was unknown.  The reporter's assessment of causality for the events was not applicable.  Additional information received on 31 Dec 2020: Events updated.  Follow up received on 23Mar2021, included no new information.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Narrative: 1/21/21- dose 1 of pfizer vaccine 2/10/21- dose 2 of pfizer vaccine 7/18- covid+ (outside lab) 8/1- reports that still feeling unwell from COVID, cough is worse 8/2- reports cough, fatigue, headache, loss of taste/smell, runny nose, dyspnea,sore throat 8/8- improving, still reports cough/fatigue/loss of taste/smell
Patient give Pfizer Covid 19.   Patient   reported issues breathing.  Patient given benadryl.  911 called and instructed to administer epipen.  Patient had multiple seizures.  Patient transported to hospital by ambulance.
No adverse event at this time.  Client was given boostrix - GSK Tdap.  Tdap is not age appropriate.  Not licensed for 19 and up.  CDC hotline - There was no need to repeat vaccine but need to report to VAERS.
Patient is a 26 y.o. female admitted to the hospital on 12/6/2022 for shortness of breath in the setting of recent positive COVID-19 test. She required supplemental oxygen on admission but was weaned to room air. Her Paxlovid was continued and she was treated for asthma exacerbation as well as vocal cord dysfunction. Her breathing improved with steroids and she was discharged home.    Discharge Diagnosis and Associated Hospital Course   Acute Hypoxemic Respiratory Failure, Resolved - Likely caused by asthma exacerbation in setting of COVID-19, hx of vocal cord dysfunction d/t numerous past intubations - CXR on admission non-acute - Initially noted to be on 6L NC and was weaned to room air with treatment below    Lactic Acidosis Elevated Anion Gap Metabolic Acidosis - likely secondary to albuterol inhaler  - Lactic acid up-trended to 5.9 on 12/8/2022, initially improved and up-trended prior to discharge - CT 12/8 with no acute intraabdominal processes. Stable hepatomegaly. - Strict ER return precautions given    Moderate Asthma Exacerbation Intermittent Asthma - Likely triggered by COVID-19. Patient reports having to use rescue inhaler once a month. Rarely daytime symptoms and no night time awakenings.  - Home regimen includes albuterol 90 mcg PRN, mometasone-formoterol 100-5 mcg/actuation, tiotropium bromide 1.25 mcg/actuation, cetirizine 10 mg IBD (noncompliant), fluticasone (noncompliant) - S/p IV methylprednisolone and transitioned to oral prednisone 4 day taper. Resumed home inhalers    COVID-19 Infection - Symptom start date 12/2/22. Positive test date 12/3/22. Was immunized  - Was started on paxlovid outpatient which was completed during admission    Vocal Cord Dysfunction - Hx of multiple intubations - continue follow-up outpatient    Stable Hepatomegaly - Unclear cause - CTAP on 12/8 revealed a stable hepatomegaly - Recommend follow up with PCP to address  Depression - Continue home zoloft 200mg dose
Patient states that she has hives on her arms and torso. She denies any SOB, wheezing, angioedema. Patient states that any time she gets a sinus infection she breaks out in similar hives. Counseled patient to take Benadryl po x1 and to monitor for worsening of signs and symptoms. told pt to go to ER if condition worsens.
Both doses are 48 days apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Both doses are 48 days apart) outcome was unknown.            Treatment information was not reported. Concomitant information was not reported.
Mouth sores, painful enough to interfere with eating for several days. Patient has no history of mouth sores.
Pt returned to clinic after leaving the site and sitting in her car for 1-2 minutes. Per pt, she began to feel "itchy" in her right arm (vaccine administered in left) and returned to clinic c/o concern for allergic reaction. Pt initially presented to RN, who notified  This RN for further assessment of the patient.    Upon initial assessment, pt appeared anxious and was c/o itching in her bilateral arms, pressure and "tightness" in her chest. Approximately 3 in x 3 in area of erythema visualized to upper right arm, with 3 hives surrounding the area. No erythema visualized to vaccine site, however, 2 hives were visualized to right upper arm. No diffuse erythema or hives noted. Lungs CTA bilaterally, HR 76 w/palpation. Site Manager, and RN to pt's side. EMS contacted. This RN waited at pt's side for continued assessment while awaiting EMS.  Electronically signed by RN at 2/5/2021 16:00
Tickling sensation in throat that progressed in one hour to tightness in throat with difficulty swallowing. Developed blurred vision with bloodshot eyes and drainage from eyes by 11:30AM. Contacted family provider who saw client and treated her with cortisone injection and oral Benadryl. Also prescribed a Prednisone Dosepak. Symptoms improved following Cortisone injection and Benadryl.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 11-AUG-2015 the patient was inadvertently vaccinated with a dose of expired RECOMBIVAX HB (lot # H017304, exp. date: 11-JUL-2015) (strength was not reported) 1 ml, intramuscularly. No adverse effect was reported. Additional information has been requested.
Lymph node enlargement, neck region only, ear pain and neck tenderness. Denied fever, body aches or other symptoms.
HPV was mistakenly ordered using the EHR template for ordering vaccines, which lists vaccines alphabetically. The medical assistant did not recognize the error, and administered the vaccination, in place of HIB, which was the intended vaccination.
Sore upper arm at site of injection; redness at site of injection, fatigue, mild shivers, mild body aches, upset stomach.
Generalized edema, swelling of eyes & face; Somewhat atopic, on hypoallergic formula; sister has a lot of Upper resp problems precipitated by ear infect; Seen 23OCT90 still some puffiness of face;
Had 4 days of flu like symptoms directly after receiving the vaccine. These resolved, but some chest congestion remained. Seen in the ER on July 19th for chest pain. Worked up for cardiac and pulmonary causes, all negative. Seen in primary care on July 30 for 2 days of diarrhea, given loperamide and contingent prescription of azithromycin.
pt recv vax 7OCT94 & later that evening the pt devel a pimply rash which MD thought was folliculitis; MD did not think that the pt's exp was d/t the vax;
This spontaneous case was reported by a consumer and describes the occurrence of   in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.  No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available). In April 2020, COVID-19: Positive. On an unknown date, Pyrexia: (High) vacillated between 101 and 102. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator. No treatment medications provided by the reporter.
Administered vaccination (7/27/22) 2 days past expiration date (7/25/22), no adverse events were reported by client.
Erectile dysfunction; peripheral neuropathy; patient still experiencing both symptoms as of reporting date, ED treatments (Viagra etc have not relieved symptoms.
Pt developed varicella on 8/2/02 after being exposed to someone else. This person had received varicella vaccine on 7/3/02 and developed vaccine associated varicella on 7/22/02. The pt's condition improved after 1 week.
On 4-23-16 at 1351 patient presented to hospital with an episode of loss of consciousness, unresponsive and confusion. Potassium level was 3.0.
Caller stated that she tested positive for the Covid Virus after she received her first dose of the vaccine; Caller stated that she tested positive for the Covid Virus after she received her first dose of the vaccine; This is a spontaneous report from a contactable consumer reporting for the mother. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller, calling on behalf of mother, wanted to know if she should receive her second vaccine today while positive for the Covid Virus. Caller stated that she tested positive for the Covid Virus after she received her first dose of the vaccine. The outcome of the events was unknown.  Information on lot number/batch number has been requested.
I remainder of the day I rested.  The next day I rested all day as well and was fatigued, had a mild headache, muscle aches and felt the cold shivering feeling but had no fever.
Local reaction to influenza vaccine.  Noted blistered area at vaccination site and above vaccination site.  Area drained then scabbed over x 2.
Patient states she went to the doctor because her arm was in a lot of pain. Patient received both the influenza and pneumonia shot in same arm. Patient states doctor told her she was injected in the joint.
Started my period and since I?ve been on my iUD I have only had very light periods once every 3 months or so. I had my regular light period 3 weeks ago and suddenly I started my period about 7 hrs after my vaccine. It?s heavier than usual by probably 3 or 4 times as heavy than usual.
Localized swelling 5 1/2 x 6cm started with swelling and warmth, no streaks.
It was a application error. The collar of the needle on the syringe was loose and upon injection, sprayed heavily against my arm as I watched it running down and off my elbow. I do not believe that I received that much of the vaccine. I have tried to find some information about it online and read that another country experienced the same issue. They feel that if it leaks at all, there is no way to know how much. Being a life saving vaccine, they administered a total replacement of which ever shot, ( one or two), as the manufacturer stated it was not a problem.  I feel that I did not receive a proper vaccine or response. Any assistance or direction would be greatly appreciated.  Thank you
Caller stated that about a min after taking vaccination his head started ponding and he felt weak he had a fever of 101  he took Tylenol. Fever went down . Patient has been having headaches since receiving vaccines.  caller also said patient had hand  soreness.
WITHIN 24 HOURS OF VACCINATION, PATIENT WAS EXPERIENCING DIZZINESS, ITCHING, AND NAUSEA. AS OF 7/27/14, SYMPTOMS HAVE PROGRESSED TO BILATERAL RASH ON STOMACH, WORSENING ARTHRITIS PAIN (PATIENT CAN BARELY MOVE), DIZZINESS, NAUSEA, LOSS OF APPETITE, ITCHING, PAIN.
A few hours after the shot, I had normal localized pain but began to feel pain in my armpit of the same arm I was vaccinated in, my left arm. When I woke in the morning, the pain was very intense and ended up taking taking 2 Advil for pain relief. I also had the normal cold like symptoms such as a headache, grogginess, small cough, and fatigue. The pain persisted throughout the day. The morning of the 13th, I woke up to a ready, itchy rash on my chin and on the tops of both of my hands. My face appeared to be constantly flushed the entire day while I felt a bit woozy. The FNP I saw in the clinic stated that I appeared to be blotchy all over. The pain in my arm pit had increased to the point where I struggled to raise my arm to put my hair up in a pony tail; I took a naproxen to help. Earlier that morning I attempted to examine my armpits to look and feel if my lymph nodes appeared to be swollen as I knew it wasn't a muscular pain - I believed my left under arm lymph nodes to be swollen. The FNP gave me prednisone for the rash.
Ankle swelling with extreme foot pain(has neuropathy) No symptoms in 15 minutes after injection on both injections After the second injection had complaints of being shaky, not feeling well with generalized weakness
Lost some of vaccination out of syringe; Lost some of vaccination out of syringe; A spontaneous report was received from a pharmacist concerning a patient of an unknown age and gender who received Moderna's COVID-19 Vaccine and lost some vaccination out of syringe.  The patient's medical history was not provided. No concomitant medications were provided.  On 19 Feb 2021, prior to onset of the event lost some vaccination out of syringe, the patient received their dose of mRNA-1273 (lot/batch number: unknown) for prophylaxis of COVID-19 infection.  On 19 Feb 2021, the patient lost some vaccination out of syringe as connection between the syringe and needle was loose.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event lost some vaccination out of syringe was considered recovered.; Reporter's Comments: This reports refers to a case of Vaccine underdose AND Syringe Connection Issue for mRNA-1273 (lot number unknown) with no associated AEs. Causality for this medication error is not applic
Day 4 after vaccine: headaches, muscle aches and chills. Day 5: same plus add nausea. Day 6: fever, severe muscle aches, sore throat, and extreme fatigue. Day 7&8: non verbal from throat pain. Day 9x: woke up able to move around, headache still present, redness around injection site hot too touch and hard. Day 10: exhaustion and arm pain again. Day 11: rash covering all of chest area.
Headache, Dizziness, Brain Fog, Vertigo like symptoms. Shortness of breath.
Information has been received from a nurse concerning a females who was vaccinated in 2007 with a first dose of Gardasil. Subsequently, both patients fainted. Unspecified medical attention was sought, The patient recovered from fainting before leaving the office. No laboratory or diagnostic tests were performed. Additional information has been requested.
This spontaneous report as received from a certified medical assistant refers to multiple patients of an unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients received unspecified number of doses of improperly stored PEDVAXHIB lot # L051122 with expiration date: 12-OCT-2018 (dose and route of administration were not reported). There were no adverse effects reported. Product quality complaint (PQC) was not involved. Additional information has been requested.